The pathogen Acinetobacter baumannii can survive on hospital surfaces—without water—for months, an ability that has helped it become a leading cause of hospital-acquired infections. Now, a team of ...
XACDURO is a new FDA-approved treatment used to fight against HABP/VABP infections caused by isolates of Acinetobacter baumannii-calcoaceticus complex, which can include those resistant to carbapenems ...
Scientists pieced together the genetic history of Acinetobacter baumannii — a notoriously stubborn hospital pathogen — using ...
Scientists reveal how one of the world's deadliest superbugs evolved.
The bacterium Acinetobacter baumannii is harmless to most people. But it also causes many hospital-acquired infections in vulnerable people, and there are few antibiotics that can effectively ...
Carbapenem-resistant Acinetobacter baumannii (CRAB) was brought into the ICU, in Hangzhou, on multiple occasions as patients were admitted, creating a large 'reservoir' of the bacteria which ...
The pathogen Acinetobacter baumannii can survive on hospital surfaces -- without water -- for months, an ability that has helped it become a leading cause of hospital-acquired infections. Now, a team ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results